美国的 Sarcoidosis 治疗模式:2016-2022年
Ruchika Sangani1, Nicholas A Bosch2, Praveen Govender2
1Pulmonary Center, Boston University School of Medicine, Boston, MA; Division of Pulmonary and Critical Care Medicine, Clinical Immunology, and Allergy, David Geffen School of Medicine at UCLA, Los Angeles, CA.
几乎一半的粉症患者在诊断后的一年内开始治疗. 治疗模式各不相同,特别是在非类固醇免疫抑制剂中,这凸显了进一步研究的必要性.
科学领域:
- 类风湿病学 类风湿病学
- 肺部病理学 肺部病理学
- 皮肤病学 皮肤病学
- 免疫学 免疫学 免疫学
背景情况:
- 有限的FDA批准的药物存在于萨尔科伊多सिस.
- 在美国,关于肉病治疗的真实数据很少.
- 针对型硬化症治疗的实践模式与指导方针相比,并没有很好地描述.
研究的目的:
- 为了研究在诊断后一年内对萨尔科病症患者的治疗模式.
- 为了确定与类百发病治疗启动和选择相关的因素.
主要方法:
- 使用多中心索赔数据库对13,330名 सारकॉइडोसिस患者 (2016-2022) 的回顾性分析.
- 确定的皮质类固醇和非类固醇免疫抑制药物在诊断后一年内使用.
- 利用多变量逻辑回归来识别与治疗相关的因素.
主要成果:
- 42.5%的类发病患者在诊断后的一年内接受治疗.
- 皮质类固醇是最常见的初始治疗 (60%的治疗患者).
- 与更高的治疗几率相关的因素包括黑人种族,器官参与和特定的并发症.
结论:
- 不到一半的患者在第一年内就开始治疗型硬化症.
- 虽然治疗因素与指导方针保持一致,但非类固醇免疫抑制疗法显示出变化.
- 需要进行进一步的试验和比较疗效研究,以优化沙尔科毒症治疗.
更多相关视频
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
10:04Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
相关概念视频
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
